However, the properties of the VNTR to modulate gene expression in vitro and correlation with differential CFAP410 expression in silico allowed us to hypothesise that this domain could regulate the expression of this locus in response to the same challenge, which could result in distinct levels of protein expression that could modulate risk and progression of ALS. Here, CFAP410 is linked to amyotrophic lateral sclerosis.